Fact CheckerSign in

NCT06597409Completed

Respiratory Muscle Stretching for Improving Chest Expansion and Dyspnea in Post-Tuberculosis Bronchiectasis

Respiratory Muscle Stretching as an Adjunct to Pulmonary Rehabilitation: Outcomes in Chest Expansion, Dyspnea, and Cough in Post-Tuberculosis Bronchiectasis

Source: ClinicalTrials.gov · Last updated 25 Feb 2025

Brief summary (registry, in English)

This study intends to examine the effectiveness of adding RMS to a traditional program of pulmonary rehabilitation regarding chest expansion, dyspnea, and cough symptoms in bronchiectasis post-tuberculosis patients. Bronchiectasis, resulting from tuberculosis treatment, is characterized by restricted chest wall motility, chronic dyspnea, and an irritating cough, factors that severely impair these patients' quality of life. It is assumed that RMS improves the compliance of the chest wall, thereby enhancing respiratory mechanics and consequently reducing symptoms. The outcomes will be compared between two groups: one group with standard pulmonary rehabilitation and another group with additional RMS exercises.

Status (registry)
Completed
Study type
Interventional
Enrollment
48 (actual)
First submitted
4 Sept 2024
Start date
29 Apr 2024
Primary completion date
18 Nov 2024
Lead sponsor
Universitas Padjadjaran
Diseases
Tuberculosis
NCT number
NCT06597409

What you commit to

  • Study type: Interventional
  • Participants enrolled: 48
  • From 29 Apr 2024 to the primary completion date, 18 Nov 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • COVID-19
  • Lung malignancy
  • Chronic obstructive pulmonary disease
  • Neuromuscular disease

Other

  • Pneumothorax
  • Pleural effusion

Who the study is looking for

  • Age 18-65 years
  • History of lung TB treatment
  • Clinical or radiological diagnosis of bronchiectasis
  • mMRC Dyspnea Scale grade 1-3

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Dr. M. Goenawan Partowidigdo Lung Hospital
Coordinator of this site? Confirm its status
BogorIndonesiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.